IQVIA

What it does

IQVIA is one of the world's largest healthcare data, technology, and clinical research companies - providing pharmaceutical companies, biotech firms, and healthcare organizations with real-world evidence, clinical trial optimization, commercial analytics, and regulatory intelligence. AI capabilities include AI-powered patient identification for clinical trials that surfaces eligible patients from real-world data, ML real-world evidence analytics that analyzes patient journey data from claims, EHR, and lab records, AI sales force optimization that recommends physician targeting and call planning for pharmaceutical commercial teams, predictive market analytics that forecast drug market performance, and AI drug safety analytics that detect safety signals from pharmacovigilance data.

Strengths

• Large pharmaceutical companies, biotech organizations, and health systems use IQVIA for enterprise life sciences analytics - AI clinical trial design accelerating drug development and AI commercial analytics optimizing pharmaceutical sales force effectiveness.
• IQVIA is one of the world's largest healthcare data, technology, and clinical research companies - providing pharmaceutical companies, biotech firms, and healthcare organizations with real-world evidence, clinical trial optimization, commercial analytics, and regulatory intelligence.
• AI capabilities include AI-powered patient identification for clinical trials that surfaces eligible patients from real-world data, ML real-world evidence analytics that analyzes patient journey data from claims, EHR, and lab records, AI sales force optimization that recommends physician targeting and call planning for pharmaceutical commercial teams, predictive market analytics that forecast drug market performance, and AI drug safety analytics that detect safety signals from pharmacovigilance data.

Watch-outs

• Enterprise pharmaceutical and healthcare focus only: IQVIA serves large pharmaceutical companies and healthcare organizations — smaller biotech firms, medical devices, and non-life-sciences organizations have limited applicable use cases.
• Data access cost is significant: IQVIA's real-world evidence and market data is expensive — smaller pharmaceutical companies and researchers must carefully weigh data cost against analytical value for each engagement.
• Long-term data partnerships vs. discrete projects: IQVIA delivers maximum value through ongoing data and analytics partnerships — organizations wanting one-time analyses or short-term data access find IQVIA's commercial model less flexible than alternatives.

Pricing

IQVIA contracts vary significantly by data product, analytics scope, and engagement type. Not published. Enterprise contracts run millions annually. Annual contracts.